 | Genmab A/S | |||
| NMS : GMAB || Location: Denmark | ||||
$28.56-0.41 (-1.42%) |
0.56 M | 28.54 - 29.04 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.403 M |
| March 15, 2024 | 2.047 M |
| Feb. 29, 2024 | 1.861 M |
| Feb. 15, 2024 | 2.053 M |
| Jan. 31, 2024 | 2.053 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 23.41 | 9.67 | -58.69% |
| 09/30/2023 | 20.89 | 32.32 | 54.68% |
| 06/30/2023 | 19.99 | 20.61 | 3.11% |
| 03/31/2023 | 5.45 | 3.43 | -37.05% |
| 12/31/2022 | 26.62 | 8.77 | -67.05% |
GMAB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 649.930M | Shares Float | 64.672M |
| Short Float | 2.403M | Market Cap | 18562.00M |
| Institution ownership | 7.22% | Insider ownership | 0.007% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | 0.94 | Forward EPS | 1.50 |